MILESTONE SCIENTIFIC INC (MLSS) Fundamental Analysis & Valuation

NYSEARCA:MLSS • US59935P2092

Current stock price

0.336 USD
0 (-1.18%)
Last:

This MLSS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MLSS Profitability Analysis

1.1 Basic Checks

  • MLSS had negative earnings in the past year.
  • MLSS had a negative operating cash flow in the past year.
  • In the past 5 years MLSS always reported negative net income.
  • In the past 5 years MLSS always reported negative operating cash flow.
MLSS Yearly Net Income VS EBIT VS OCF VS FCFMLSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • MLSS has a Return On Assets of -73.30%. This is in the lower half of the industry: MLSS underperforms 75.40% of its industry peers.
  • With a Return On Equity value of -203.45%, MLSS is not doing good in the industry: 77.01% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -73.3%
ROE -203.45%
ROIC N/A
ROA(3y)-60.78%
ROA(5y)-56.07%
ROE(3y)-123.58%
ROE(5y)-99.51%
ROIC(3y)N/A
ROIC(5y)N/A
MLSS Yearly ROA, ROE, ROICMLSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 71.40%, MLSS belongs to the top of the industry, outperforming 80.75% of the companies in the same industry.
  • MLSS's Gross Margin has been stable in the last couple of years.
  • MLSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.68%
GM growth 5Y1.42%
MLSS Yearly Profit, Operating, Gross MarginsMLSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. MLSS Health Analysis

2.1 Basic Checks

  • MLSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MLSS has more shares outstanding
  • MLSS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MLSS has a worse debt to assets ratio.
MLSS Yearly Shares OutstandingMLSS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MLSS Yearly Total Debt VS Total AssetsMLSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • MLSS has an Altman-Z score of -21.45. This is a bad value and indicates that MLSS is not financially healthy and even has some risk of bankruptcy.
  • MLSS has a Altman-Z score of -21.45. This is amonst the worse of the industry: MLSS underperforms 89.30% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that MLSS is not too dependend on debt financing.
  • MLSS has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -21.45
ROIC/WACCN/A
WACC8.86%
MLSS Yearly LT Debt VS Equity VS FCFMLSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that MLSS should not have too much problems paying its short term obligations.
  • MLSS has a worse Current ratio (1.81) than 68.98% of its industry peers.
  • A Quick Ratio of 0.55 indicates that MLSS may have some problems paying its short term obligations.
  • The Quick ratio of MLSS (0.55) is worse than 91.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.55
MLSS Yearly Current Assets VS Current LiabilitesMLSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MLSS Growth Analysis

3.1 Past

  • MLSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
  • Looking at the last year, MLSS shows a small growth in Revenue. The Revenue has grown by 3.99% in the last year.
  • Measured over the past years, MLSS shows a quite strong growth in Revenue. The Revenue has been growing by 10.53% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.67%
Revenue 1Y (TTM)3.99%
Revenue growth 3Y0.62%
Revenue growth 5Y10.53%
Sales Q2Q%2.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.29% on average over the next years. This is quite good.
  • Based on estimates for the next years, MLSS will show a quite strong growth in Revenue. The Revenue will grow by 8.25% on average per year.
EPS Next Y27.14%
EPS Next 2Y16.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.51%
Revenue Next 2Y8.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MLSS Yearly Revenue VS EstimatesMLSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
MLSS Yearly EPS VS EstimatesMLSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

0

4. MLSS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MLSS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MLSS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLSS Price Earnings VS Forward Price EarningsMLSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLSS Per share dataMLSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

  • MLSS's earnings are expected to grow with 16.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MLSS Dividend Analysis

5.1 Amount

  • No dividends for MLSS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MLSS Fundamentals: All Metrics, Ratios and Statistics

MILESTONE SCIENTIFIC INC

NYSEARCA:MLSS (4/23/2026, 10:31:31 AM)

0.336

0 (-1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31
Earnings (Next)05-14
Inst Owners5.62%
Inst Owner Change0%
Ins Owners2.87%
Ins Owner Change-0.77%
Market Cap27.03M
Revenue(TTM)8.97M
Net Income(TTM)-5.72M
Analysts82.5
Price Target1.02 (203.57%)
Short Float %0.13%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.84%
Min EPS beat(2)15.03%
Max EPS beat(2)34.64%
EPS beat(4)2
Avg EPS beat(4)-19.28%
Min EPS beat(4)-96.08%
Max EPS beat(4)34.64%
EPS beat(8)3
Avg EPS beat(8)-57.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.97%
Min Revenue beat(2)-12.65%
Max Revenue beat(2)2.7%
Revenue beat(4)1
Avg Revenue beat(4)-8.11%
Min Revenue beat(4)-12.65%
Max Revenue beat(4)2.7%
Revenue beat(8)1
Avg Revenue beat(8)-12.55%
Revenue beat(12)3
Avg Revenue beat(12)-10.29%
Revenue beat(16)5
Avg Revenue beat(16)-10.64%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)25%
EPS NQ rev (3m)25%
EPS NY rev (1m)25%
EPS NY rev (3m)25%
Revenue NQ rev (1m)-4.25%
Revenue NQ rev (3m)-4.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.01
P/FCF N/A
P/OCF N/A
P/B 9.61
P/tB 9.89
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.11
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -73.3%
ROE -203.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.4%
FCFM N/A
ROA(3y)-60.78%
ROA(5y)-56.07%
ROE(3y)-123.58%
ROE(5y)-99.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.68%
GM growth 5Y1.42%
F-Score2
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.31%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.55
Altman-Z -21.45
F-Score2
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)18.04%
Cap/Depr(5y)19.87%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.67%
EPS Next Y27.14%
EPS Next 2Y16.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.99%
Revenue growth 3Y0.62%
Revenue growth 5Y10.53%
Sales Q2Q%2.23%
Revenue Next Year7.51%
Revenue Next 2Y8.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.11%
OCF growth 3YN/A
OCF growth 5YN/A

MILESTONE SCIENTIFIC INC / MLSS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MILESTONE SCIENTIFIC INC?

ChartMill assigns a fundamental rating of 1 / 10 to MLSS.


What is the valuation status of MILESTONE SCIENTIFIC INC (MLSS) stock?

ChartMill assigns a valuation rating of 0 / 10 to MILESTONE SCIENTIFIC INC (MLSS). This can be considered as Overvalued.


How profitable is MILESTONE SCIENTIFIC INC (MLSS) stock?

MILESTONE SCIENTIFIC INC (MLSS) has a profitability rating of 1 / 10.


Can you provide the financial health for MLSS stock?

The financial health rating of MILESTONE SCIENTIFIC INC (MLSS) is 1 / 10.